scholarly article | Q13442814 |
P2093 | author name string | Thomas J | |
Carde P | |||
Hayat M | |||
Tubiana M | |||
Henry-Amar M | |||
Tanguy A | |||
Noordijk EM | |||
Van der Schueren E | |||
Burgers JM | |||
Meerwaldt JH | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 47-56 | |
P577 | publication date | 1989-01-01 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987. | |
P478 | volume | 73 |
Q71952238 | A 37-year-old man with cholestatic jaundice and a prior history of Hodgkin's disease |
Q40575600 | ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II. |
Q28078115 | ACR Appropriateness Criteria® Recurrent Hodgkin Lymphoma |
Q93134714 | Assessment of the Neutrophil-Lymphocyte Ratio in Classic Hodgkin Lymphoma Patients |
Q35606768 | Changing patterns in the clinical pathological features of hodgkin lymphoma: a report from debrecen, hungary |
Q51050643 | Clinical characteristics and prognostic factors in Chinese patients with Hodgkin's lymphoma. |
Q93261031 | Current considerations in AYA Hodgkin lymphoma |
Q35117413 | Current therapies in Hodgkin's disease |
Q46666583 | Early prediction of response to therapy: the clinical implications in Hodgkin's and non-Hodgkin's lymphoma |
Q36722986 | Early stage Hodgkin's disease in adults: which is the correct treatment? |
Q48346165 | Excess mortality among 10-year survivors of classical Hodgkin lymphoma in adolescents and young adults. |
Q35822699 | Hodgkin's disease--I: Identification and classification |
Q35662615 | Hodgkin's lymphoma. II: Treatment and delayed morbidity |
Q71141093 | Is laparoscopic splenectomy appropriate for the management of hematologic and oncologic diseases? |
Q31153389 | Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL)-clinicopathological features based on the data of two Hungarian lymphoma centres |
Q93789904 | PANEL DISCUSSION: MYELOMA &LYMPHOMA: Tuesday 12 October 2004, 14:00–16:00 |
Q34235785 | Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma |
Q39976522 | Role of imaging to choose treatment |
Q35977542 | Serum lactate dehydrogenase level as a prognostic factor in Hodgkin's disease. |
Q34486551 | Stage I-IIA non-bulky Hodgkin's lymphoma. Is further distinction based on prognostic factors useful? The Stanford experience |
Q26781731 | Systematic review and meta-analysis on the prognostic value of complete remission status at FDG-PET in Hodgkin lymphoma after completion of first-line therapy |
Q54983414 | The role of primary lymph node sites in survival and mortality prediction in Hodgkin lymphoma: a SEER population-based retrospective study. |
Q54304195 | The scientific bases of cancer management: at the interface between fundamental research and clinical practice. |
Q35667908 | Variables affecting survival after second primary lung cancer: A population-based study of 187 Hodgkin's lymphoma patients |